- Home
- BFRI vs HSCS Comparison
BFRI vs HSCS Comparison
Compare BFRI & HSCS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BFRI
- HSCS
- Stock Information
- Founded
- BFRI 1997
- HSCS 2007
- Country
- BFRI United States
- HSCS United States
- Employees
- BFRI N/A
- HSCS N/A
- Industry
- BFRI Biotechnology: Pharmaceutical Preparations
- HSCS Medical Specialities
- Sector
- BFRI Health Care
- HSCS Health Care
- Exchange
- BFRI Nasdaq
- HSCS Nasdaq
- Market Cap
- BFRI 7.9M
- HSCS 8.7M
- IPO Year
- BFRI 2021
- HSCS 2022
- Fundamental
- Price
- BFRI $0.84
- HSCS $3.33
- Analyst Decision
- BFRI Strong Buy
- HSCS Strong Buy
- Analyst Count
- BFRI 1
- HSCS 2
- Target Price
- BFRI $2.75
- HSCS $13.00
- AVG Volume (30 Days)
- BFRI 347.9K
- HSCS 80.2K
- Earning Date
- BFRI 08-13-2025
- HSCS 09-09-2025
- Dividend Yield
- BFRI N/A
- HSCS N/A
- EPS Growth
- BFRI N/A
- HSCS N/A
- EPS
- BFRI N/A
- HSCS N/A
- Revenue
- BFRI $39,188,000.00
- HSCS $4,350.00
- Revenue This Year
- BFRI $11.07
- HSCS $13,968.97
- Revenue Next Year
- BFRI $11.20
- HSCS $166.67
- P/E Ratio
- BFRI N/A
- HSCS N/A
- Revenue Growth
- BFRI 11.20
- HSCS N/A
- 52 Week Low
- BFRI $0.54
- HSCS $2.36
- 52 Week High
- BFRI $2.22
- HSCS $6.47
- Technical
- Relative Strength Index (RSI)
- BFRI 42.93
- HSCS 43.80
- Support Level
- BFRI $0.82
- HSCS $3.24
- Resistance Level
- BFRI $0.95
- HSCS $3.59
- Average True Range (ATR)
- BFRI 0.07
- HSCS 0.23
- MACD
- BFRI -0.01
- HSCS -0.01
- Stochastic Oscillator
- BFRI 20.70
- HSCS 13.04
About BFRI Biofrontera Inc.
Biofrontera Inc is a United States-based biopharmaceutical company commercializing a portfolio of pharmaceutical products for the treatment of dermatological conditions with a focus on photodynamic therapy. The Company's licensed products, which include Ameluz as well as the BF-RhodoLED and RhodoLED XL lamps (together, the RhodoLED Lamps), are used for the treatment of actinic keratoses (AKs), which are pre-cancerous skin lesions.
About HSCS Heart Test Laboratories Inc.
HeartSciences Inc is an artificial intelligence (AI)-powered medical technology company focused on transforming ECGs/EKGs to save lives through earlier detection of heart disease. Its objective is to improve healthcare by making it a far more valuable cardiac screening tool, particularly in frontline or point-of-care clinical settings. It is developing a suite of AI-ECG diagnostic solutions for use in any healthcare care setting, either via MyoVista Insights cloud-platform using one of the millions of ECG devices currently in clinical use or via MyoVista wavECG Device.